US · Healthcare

Acura Pharmaceuticals Inc (ACUR)

Drug Manufacturers - Specialty & Generic

Acura Pharmaceuticals Inc (ACUR) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ACUR

P/E ratio

18.00

Acura Pharmaceuticals Inc (ACUR) — FAQ

What is ACUR's P/E ratio?

The price-to-earnings (P/E) ratio for Acura Pharmaceuticals Inc (ACUR) is 18.00 (data as of 2026-03-23).

Does Acura Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Acura Pharmaceuticals Inc (ACUR). Check the MyAverix Finance app for the latest dividend data.

What sector is Acura Pharmaceuticals Inc in?

Acura Pharmaceuticals Inc (ACUR) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ACUR listed on?

ACUR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)